Masako Arimura-Omori Selected Research

Tumor Suppressor p53-Binding Protein 1

4/2021

The Association of Aging-Related Polymorphisms with Susceptibility to Lung Cancer: A Case-Control Study in a Japanese Population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masako Arimura-Omori Research Topics

Disease

3	Sarcoidosis (Schaumann Disease) 09/2021 - 01/2017
3	Neoplasms (Cancer) 04/2021 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 04/2015
2	Lung Injury 12/2017 - 01/2017
2	Pneumonia (Pneumonitis) 01/2017 - 01/2017
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Eosinophilia 01/2021
1	Allergic Bronchopulmonary Aspergillosis 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Pulmonary Sarcoidosis 01/2017
1	Cysts 04/2015

Drug/Important Bio-Agent (IBA)

3	Tyrosine Kinase InhibitorsIBA 01/2017 - 04/2015
2	Immune Checkpoint ProteinsIBA 09/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 04/2021 - 03/2020
2	OligosaccharidesIBA 04/2021 - 03/2020
2	OligonucleotidesIBA 04/2021 - 03/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2021 - 03/2020
2	telomerase RNA (bTR)IBA 04/2021 - 03/2020
2	Gefitinib (Iressa)FDA Link 01/2017 - 01/2017
2	naphthaleneIBA 01/2017 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 01/2017
1	Tumor Suppressor p53-Binding Protein 1IBA 04/2021
1	benralizumabIBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2017
1	Peptides (Polypeptides)IBA 12/2017
1	AntibodiesIBA 01/2017
1	LigandsIBA 01/2017
1	AfatinibIBA 01/2017
1	sivelestatIBA 01/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	CytokinesIBA 01/2017
1	Secretory Proteinase Inhibitory ProteinsIBA 01/2017
1	CrizotinibIBA 04/2015
1	Anaplastic Lymphoma KinaseIBA 04/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2015

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2017
1	Therapeutics 04/2015